Health
FDA grants rare disease designations to investigational brain tumor drug – News-Medical.Net
The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational drug discovered at the Oklahom…
Reviewed by Emily Henderson, B.Sc.Sep 2 2020
The U.S. Food and Drug Administration has awarded Rare Pediatric Disease Designation (RPDD) for diffuse intrinsic pontine glioma (DIPG) and Orphan Drug Designation for treatment of malignant glioma to OKN-007, an investigational drug discovered at the Oklahoma Medical Research Foundation and being developed by Oblato, Inc.
DIPG is a fast-growing pediatric cancer that starts in the brain stem. It is one of several sub-categories of malignant gliomas,…
-
Noosa News22 hours agoLightning halts women’s rugby Test as ‘humdinger’ winter storm lashes Brisbane
-
Noosa News22 hours agoQueensland Premier David Crisafulli throws his support behind controversial beach clubs for the Gold Coast
-
General22 hours agoWallabies vs British and Irish Lions second Test in Melbourne live updates
-
General22 hours agoHong Kong police issue arrest warrants for foreign nationals including Australian citizen Feng Chongyi